Nordic Reference Laboratory for Genomic Blood Group Typing and the Department of Clinical Immunology and Transfusion Medicine, Office of Medical ServicesSkåne, Sweden
Transfusion Medicine at the Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, and the Faculty of Medicine, Lund UniversityLund, Sweden
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hellberg Å, Westman JS, Thuresson B, Olsson ML. P1PK: the blood group system that changed its name and expanded. Immunohematology 2013;29:25–33.HellbergÅWestmanJSThuressonBOlssonML.P1PK: the blood group system that changed its name and expanded.Immunohematology2013;29:25–33.10.21307/immunohematology-2019-120Search in Google Scholar
Veldhuisen B, van der Schoot CE, de Haas M. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009;97:198–206.VeldhuisenBvan der SchootCEde HaasM.Blood group genotyping: from patient to high-throughput donor screening.Vox Sang2009;97:198–206.10.1111/j.1423-0410.2009.01209.xSearch in Google Scholar
Bezirgiannidou Z, Christoforidou A, Kontekaki E, et al. Hyperhemolytic syndrome complicating a delayed hemolytic transfusion reaction due to anti-P1 alloimmunization, in a pregnant woman with HbO-Arab/ß-thalassemia. Mediterr J Hematol Infect Dis 2016;8:e2016053.BezirgiannidouZChristoforidouAKontekakiE,Hyperhemolytic syndrome complicating a delayed hemolytic transfusion reaction due to anti-P1 alloimmunization, in a pregnant woman with HbO-Arab/ß-thalassemia.Mediterr J Hematol Infect Dis2016;8:e2016053.10.4084/mjhid.2016.053Search in Google Scholar
Smith D, Aye T, Er LS, Nester T, Delaney M. Acute hemolytic transfusion reaction due to anti-P1: a case report and review of institutional experience. Transfus Med Hemother 2019;46:381–4.SmithDAyeTErLSNesterTDelaneyM.Acute hemolytic transfusion reaction due to anti-P1: a case report and review of institutional experience.Transfus Med Hemother2019;46:381–4.10.1159/000490897Search in Google Scholar
Kaczmarek R, Duk M, Szymczak K, et al. Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating P(k), P1 and NOR blood group antigens. Biochem Biophys Res Comm 2016;470:168–74.KaczmarekRDukMSzymczakK,Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating P(k), P1 and NOR blood group antigens.Biochem Biophys Res Comm2016;470:168–74.10.1016/j.bbrc.2016.01.017Search in Google Scholar
Haselberger SG, Schenkel-Brunner H. Evidence for erythrocyte membrane glycoproteins being carriers of blood-group P1 determinants. FEBS Lett 1982;149:126–8.HaselbergerSGSchenkel-BrunnerH.Evidence for erythrocyte membrane glycoproteins being carriers of blood-group P1 determinants.FEBS Lett1982;149:126–8.10.1016/0014-5793(82)81086-7Search in Google Scholar
Yang Z, Bergström J, Karlsson K-A. Glycoproteins with Galalpha4Gal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities. J Biol Chem 1994;269:14620–4.YangZBergströmJKarlssonK-A.Glycoproteins with Galalpha4Gal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities.J Biol Chem1994;269:14620–4.10.1016/S0021-9258(17)36669-3Search in Google Scholar
Stenfelt L, Westman JS, Hellberg A, Olsson ML. The P1 histo-blood group antigen is present on human red blood cell glycoproteins. Transfusion 2019;59:1108–17.StenfeltLWestmanJSHellbergAOlssonML.The P1 histo-blood group antigen is present on human red blood cell glycoproteins.Transfusion2019;59:1108–17.10.1111/trf.1511530597575Search in Google Scholar
Szymczak-Kulus K, Weidler S, Bereznicka A, et al. Novel bisgalactosylated type of N-glycans as decoy receptors for Shiga toxin? Glycoconj J 2019;36:369.Szymczak-KulusKWeidlerSBereznickaA,Novel bisgalactosylated type of N-glycans as decoy receptors for Shiga toxin?Glycoconj J2019;36:369.Search in Google Scholar
Tsering D, Chen C, Ye J, et al. Enzymatic synthesis of human blood group P1 pentasaccharide antigen. Carbohydr Res 2017;438:39–43.TseringDChenCYeJ,Enzymatic synthesis of human blood group P1 pentasaccharide antigen.Carbohydr Res2017;438:39–43.10.1016/j.carres.2016.11.01927960098Search in Google Scholar
Jacob F, Alam S, Konantz M, et al. Transition of mesenchymal and epithelial cancer cells depends on alpha1-4 galactosyltransferase-mediated glycosphingolipids. Cancer Res 2018;78:2952–65.JacobFAlamSKonantzM,Transition of mesenchymal and epithelial cancer cells depends on alpha1-4 galactosyltransferase-mediated glycosphingolipids.Cancer Res2018;78:2952–65.10.1158/0008-5472.CAN-17-222329572228Search in Google Scholar
Breton C, Snajdrova L, Jeanneau C, Koca J, Imberty A. Structures and mechanisms of glycosyltransferases. Glycobiology 2006;16:29R–37R.BretonCSnajdrovaLJeanneauCKocaJImbertyA.Structures and mechanisms of glycosyltransferases.Glycobiology2006;16:29R–37R.10.1093/glycob/cwj01616037492Search in Google Scholar
Pacheco AR, Lazarus JE, Sit B, et al. CRISPR screen reveals that EHEC’s T3SS and shiga toxin rely on shared host factors for infection. MBio 2018;9:e011003–18.PachecoARLazarusJESitB,CRISPR screen reveals that EHEC’s T3SS and shiga toxin rely on shared host factors for infection.MBio2018;9:e011003–18.10.1128/mBio.01003-18601624329921669Search in Google Scholar
Tian S, Muneeruddin K, Choi MY, et al. Genome-wide CRISPR screens for Shiga toxins and ricin reveal Golgi proteins critical for glycosylation. PLoS Biol 2018;16:e2006951.TianSMuneeruddinKChoiMY,Genome-wide CRISPR screens for Shiga toxins and ricin reveal Golgi proteins critical for glycosylation.PLoS Biol2018;16:e2006951.10.1371/journal.pbio.2006951625847230481169Search in Google Scholar
Yamaji T, Sekizuka T, Tachida Y, et al. A CRISPR screen identifies LAPTM4A and TM9SF proteins as glycolipid-regulating factors. iScience 2019;11:409–24.YamajiTSekizukaTTachidaY,A CRISPR screen identifies LAPTM4A and TM9SF proteins as glycolipid-regulating factors.iScience2019;11:409–24.10.1016/j.isci.2018.12.039634830330660999Search in Google Scholar
Cabrita MA, Hobman TC, Hogue DL, King KM, Cass CE. Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes. Cancer Res 1999;59:4890–7.CabritaMAHobmanTCHogueDLKingKMCassCE.Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes.Cancer Res1999;59:4890–7.Search in Google Scholar
Möller M, Jöud M, Storry JR, Olsson ML. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Adv 2016;1:240–9.MöllerMJöudMStorryJROlssonML.Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project.Blood Adv2016;1:240–9.10.1182/bloodadvances.2016001867573716829296939Search in Google Scholar
Shastry S, Satyamoorthy K, Acharya KV, et al. Deletion in the A4GALT gene associated with rare “P null” phenotype: the first report from India. Transfus Med Hemother 2020;47:186–9.ShastrySSatyamoorthyKAcharyaKV,Deletion in the A4GALT gene associated with rare “P null” phenotype: the first report from India.Transfus Med Hemother2020;47:186–9.10.1159/000501916718482532355479Search in Google Scholar
Tilley L, McNeill A, Baglow L, et al. Two novel A4GALT null alleles detected in patients with the p phenotype (abstract). Br Blood Transfus Soc Ann Conf 2019;127.TilleyLMcNeillABaglowL,Two novel A4GALT null alleles detected in patients with the p phenotype (abstract).Br Blood Transfus Soc Ann Conf2019;127.Search in Google Scholar
Westman JS, Hellberg Å, Peyrard T, Thuresson B, Olsson ML. Large deletions involving the regulatory upstream regions of A4GALT give rise to principally novel P1PK-null alleles. Transfusion 2014;54:1831–5.WestmanJSHellberg Å, PeyrardTThuressonBOlssonML.Large deletions involving the regulatory upstream regions of A4GALT give rise to principally novel P1PK-null alleles.Transfusion2014;54:1831–5.10.1111/trf.1254324417201Search in Google Scholar
Thuresson B, Westman JS, Olsson ML. Identification of a novel A4GALT exon reveals the genetic basis of the P1/P2 histo-blood groups. Blood 2011;117:678–87.ThuressonBWestmanJSOlssonML.Identification of a novel A4GALT exon reveals the genetic basis of the P1/P2 histo-blood groups.Blood2011;117:678–87.10.1182/blood-2010-08-30133320971946Search in Google Scholar
Lai YJ, Wu WY, Yang CM, et al. A systematic study of single-nucleotide polymorphisms in the A4GALT gene suggests a molecular genetic basis for the P1/P2 blood groups. Transfusion 2014;54:3222–31.LaiYJWuWYYangCM,A systematic study of single-nucleotide polymorphisms in the A4GALT gene suggests a molecular genetic basis for the P1/P2 blood groups.Transfusion2014;54:3222–31.10.1111/trf.1277125041587Search in Google Scholar
Iwamura K, Furukawa K, Uchikawa M, et al. The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene: a clue to the solution of the P1/P2/p puzzle. J Biol Chem 2003;278:44429–38.IwamuraKFurukawaKUchikawaM,The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene: a clue to the solution of the P1/P2/p puzzle.J Biol Chem2003;278:44429–38.10.1074/jbc.M30160920012888565Search in Google Scholar
Eernstman J, Veldhuisen B, Heshusius S, et al. KLF1 regulates P1 expression through transcriptional control of A4GALT. Vox Sang 2017;112:25(3B-S06-2).EernstmanJVeldhuisenBHeshusiusS,KLF1 regulates P1 expression through transcriptional control of A4GALT.Vox Sang2017;112:25(3B-S06-2).Search in Google Scholar
Singleton BK, Burton NM, Green C, Brady RL, Anstee DJ. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 2008;112:2081–8.SingletonBKBurtonNMGreenCBradyRLAnsteeDJ.Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype.Blood2008;112:2081–8.10.1182/blood-2008-03-14567218487511Search in Google Scholar
Kawai M, Obara K, Onodera T, et al. Mutations of the KLF1 gene detected in Japanese with the In(Lu) phenotype. Transfusion 2017;57:1072–7.KawaiMObaraKOnoderaT,Mutations of the KLF1 gene detected in Japanese with the In(Lu) phenotype.Transfusion2017;57:1072–7.10.1111/trf.1399028194794Search in Google Scholar
Westman JS, Stenfelt L, Vidovic K, et al. Allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT. Blood 2018;131:1611–6.WestmanJSStenfeltLVidovicK,Allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT.Blood2018;131:1611–6.10.1182/blood-2017-08-80308029438961Search in Google Scholar
Yeh CC, Chang CJ, Twu YC, et al. The differential expression of the blood group P(1)-A4GALT and P(2)-A4GALT alleles is stimulated by the transcription factor early growth response 1. Transfusion 2018;58:1054–64.YehCCChangCJTwuYC,The differential expression of the blood group P(1)-A4GALT and P(2)-A4GALT alleles is stimulated by the transcription factor early growth response 1.Transfusion2018;58:1054–64.10.1111/trf.1451529399809Search in Google Scholar
Kaczmarek R, Szymczak-Kulus K, Bereznicka A, et al. Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system. PLoS One 2018;13:e0196627.KaczmarekRSzymczak-KulusKBereznickaA,Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system.PLoS One2018;13:e0196627.10.1371/journal.pone.0196627592744429709005Search in Google Scholar
Levine P. Illegitimate blood group antigens P1, A, and MN (T) in malignancy—a possible therapeutic approach with anti-Tja, anti-A, and anti-T. Ann N Y Acad Sci 1976;277:428–35.LevineP.Illegitimate blood group antigens P1, A, and MN (T) in malignancy—a possible therapeutic approach with anti-Tja, anti-A, and anti-T.Ann N Y Acad Sci1976;277:428–35.10.1111/j.1749-6632.1976.tb41719.x793484Search in Google Scholar
Jacob F, Goldstein DR, Bovin NV, et al. Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. Int J Cancer 2012;130:138–46.JacobFGoldsteinDRBovinNV,Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array.Int J Cancer2012;130:138–46.10.1002/ijc.26002313766721351089Search in Google Scholar
Jacob F, Anugraham M, Pochechueva T, et al. The glycosphingolipid P(1) is an ovarian cancer-associated carbohydrate antigen involved in migration. Br J Cancer 2014;111:1634–45.JacobFAnugrahamMPochechuevaT,The glycosphingolipid P(1) is an ovarian cancer-associated carbohydrate antigen involved in migration.Br J Cancer2014;111:1634–45.10.1038/bjc.2014.455420009525167227Search in Google Scholar
Puri A, Rawat SS, Lin HM, et al. An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells. AIDS 2004;18:849–58.PuriARawatSSLinHM,An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells.AIDS2004;18:849–58.10.1097/00002030-200404090-0000215060432Search in Google Scholar
Hammache D, Yahi N, Maresca M, Pieroni G, Fantini J. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J Virol 1999;73:5244–8.HammacheDYahiNMarescaMPieroniGFantiniJ.Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3).J Virol1999;73:5244–8.10.1128/JVI.73.6.5244-5248.199911257810233996Search in Google Scholar
Lund N, Olsson ML, Ramkumar S, et al. The human P(k) histo-blood group antigen provides protection against HIV-1 infection. Blood 2009;113:4980–91.LundNOlssonMLRamkumarS,The human P(k) histo-blood group antigen provides protection against HIV-1 infection.Blood2009;113:4980–91.10.1182/blood-2008-03-14339619139081Search in Google Scholar
Motswaledi MS, Kasvosve I, Oguntibeju OO. Blood group antigens C, Lub and P1 may have a role in HIV infection in Africans. PLoS One 2016;11:e0149883.MotswalediMSKasvosveIOguntibejuOO.Blood group antigens C, Lub and P1 may have a role in HIV infection in Africans.PLoS One2016;11:e0149883.10.1371/journal.pone.0149883476429526900853Search in Google Scholar